Trial intelligence / Profile preview

Enoxaparin and aspirin for mobility problems after non-hemorrhagic stroke

IRCT201109067495N1Phase 2Completed

Sponsor
Shahrekord University of Medical Sciences
Start
Mar 2009
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 2 trial of enoxaparin and aspirin in ischemic stroke (2 arms), sponsored by Shahrekord University of Medical Sciences. Started Mar 2009; status: completed.

02

Drugs

enoxaparinaspirin
03

Conditions

ischemic stroke

Beyond the preview

Go deeper on IRCT201109067495N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT201109067495N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call